Skip to main content
Equibles

BESSEMER GROUP INC

Position in NVS — Novartis AG

CIK 1054074 WOODBRIDGE, NJ
Back to NVS Full portfolio

Position in NVS

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$10,183,191
+$1,161,626 QoQ
Shares Held
64,977
+10.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#174
of 1,611 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 61% Shared 0% None 39%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

BESSEMER GROUP INC holds $2,467,290,706 across 16 Drug Manufacturers - General names. NVS ranks #8 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
 923,815 $1,108,051,512
2 ABBV
AbbVie Inc.
 2,954,184 $743,390,856
3 GILD
Gilead Sciences, Inc.
 1,444,022 $182,437,735
4 MRK
Merck & Co., Inc.
 1,080,415 $138,833,324
5 JNJ
Johnson & Johnson
 539,958 $137,133,128
6 PFE
Pfizer Inc
 5,067,281 $122,020,120
7 AMGN
Amgen Inc
 31,001 $11,226,079
8 NVS
Novartis AG
This page 		64,977 $10,183,191

All Filings in NVS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,183,191 64,977
2026-03-31 $9,021,565 59,061
2025-12-31 $5,569,948 40,412
2025-09-30 $2,046,453 15,976
2025-06-30 $1,884,487 15,573
2025-03-31 $1,258,496 11,289
2024-12-31 $991,002 10,184
2024-09-30 $1,304,789 11,374
2024-06-30 $1,321,592 12,414
2024-03-31 $1,216,184 12,573
2023-12-31 $1,511,621 14,971
2023-09-30 $1,498,154 14,708
2023-06-30 $1,653,205 16,383
2023-03-31 $1,432,900 15,575
2022-12-31 $1,539,244 16,967
2022-09-30 $1,671,914 21,996
2022-06-30 $1,507,759 17,837
2022-03-31 $1,588,097 18,098
2021-12-31 $1,771,354 20,251
2021-09-30 $1,764,319 21,574
2021-06-30 $2,013,209 22,065
2021-03-31 $1,817,474 21,262
2020-12-31 $1,385,096 14,668
2020-09-30 $1,246,483 14,334
2020-06-30 $1,205,989 13,808
2020-03-31 $1,210,448 14,681